Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Zebrafish
|
February 6, 2008
A "block and rescue" pharmacogenetic approach to dissecting a biochemical pathway controlling germ cell migration
Timothy S Mulligan, Steven A Farber
Microvascular Research
|
June 15, 2014
Emerging from the PAC: studying zebrafish lymphatic development
Timothy S Mulligan, Brant M Weinstein
Methods in Molecular Biology (Clifton, N.J.)
|
September 5, 2023
Selective Cell Ablation Using an Improved Prodrug-Converting Nitroreductase
Timothy S Mulligan, Jeff S Mumm
Development (Cambridge, England)
|
May 17, 2017
Development of the larval lymphatic system in zebrafish
Hyun Min Jung, Daniel Castranova, Matthew R Swift, et al.
Plos Genetics
|
November 22, 2017
mRNA processing in mutant zebrafish lines generated by chemical and CRISPR-mediated mutagenesis produces unexpected transcripts that escape nonsense-mediated decay
Jennifer L Anderson, Timothy S Mulligan, Meng-Chieh Shen, et al.
Frontiers in Cell and Developmental Biology
|
September 7, 2018
Multiplexed CRISPR/Cas9 Targeting of Genes Implicated in Retinal Regeneration and Degeneration
Arife Unal Eroglu, Timothy S Mulligan, Liyun Zhang, et al.
Molecular and Cellular Biology
|
September 8, 2016
T Cell Immune Deficiency in <i>zap70</i> Mutant Zebrafish
John C Moore, Timothy S Mulligan, Nora Torres Yordán, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
A metagenomic library cloning strategy that promotes high-level expression of captured genes to enable efficient functional screening
Michelle H Rich, Abigail V Sharrock, Timothy S Mulligan, et al.
Cell Chemical Biology
|
October 28, 2023
A metagenomic library cloning strategy that promotes high-level expression of captured genes to enable efficient functional screening
Michelle H Rich, Abigail V Sharrock, Timothy S Mulligan, et al.
Nature Methods
|
February 8, 2022
NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation
Abigail V Sharrock, Timothy S Mulligan, Kelsi R Hall, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Zebrafish
|
February 6, 2008
A "block and rescue" pharmacogenetic approach to dissecting a biochemical pathway controlling germ cell migration
Timothy S Mulligan, Steven A Farber
Microvascular Research
|
June 15, 2014
Emerging from the PAC: studying zebrafish lymphatic development
Timothy S Mulligan, Brant M Weinstein
Methods in Molecular Biology (Clifton, N.J.)
|
September 5, 2023
Selective Cell Ablation Using an Improved Prodrug-Converting Nitroreductase
Timothy S Mulligan, Jeff S Mumm
Development (Cambridge, England)
|
May 17, 2017
Development of the larval lymphatic system in zebrafish
Hyun Min Jung, Daniel Castranova, Matthew R Swift, et al.
Plos Genetics
|
November 22, 2017
mRNA processing in mutant zebrafish lines generated by chemical and CRISPR-mediated mutagenesis produces unexpected transcripts that escape nonsense-mediated decay
Jennifer L Anderson, Timothy S Mulligan, Meng-Chieh Shen, et al.
Frontiers in Cell and Developmental Biology
|
September 7, 2018
Multiplexed CRISPR/Cas9 Targeting of Genes Implicated in Retinal Regeneration and Degeneration
Arife Unal Eroglu, Timothy S Mulligan, Liyun Zhang, et al.
Molecular and Cellular Biology
|
September 8, 2016
T Cell Immune Deficiency in <i>zap70</i> Mutant Zebrafish
John C Moore, Timothy S Mulligan, Nora Torres Yordán, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
A metagenomic library cloning strategy that promotes high-level expression of captured genes to enable efficient functional screening
Michelle H Rich, Abigail V Sharrock, Timothy S Mulligan, et al.
Cell Chemical Biology
|
October 28, 2023
A metagenomic library cloning strategy that promotes high-level expression of captured genes to enable efficient functional screening
Michelle H Rich, Abigail V Sharrock, Timothy S Mulligan, et al.
Nature Methods
|
February 8, 2022
NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation
Abigail V Sharrock, Timothy S Mulligan, Kelsi R Hall, et al.
Page
of 1